Merck in supply agreement with US government for its Covid-19 treatment
Woman holds vials labelled "Covid-19 Coronavirus Vaccine" over dry ice in this illustration taken, December 5, 2020. REUTERS/Dado Ruvic/Illustration
Merck & Co said on Wednesday it will supply about 60,000-100,000 doses of its Covid-19 treatment to the US government for up to about $356 million.
The agreement will help support advanced development and large-scale manufacturing of Merck's investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical Covid-19, The US Department of the Health and Human Services said.
Keep updated, follow The Business Standard's Google news channel
